WntResearch AB (NGM:WNT)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.4930
+0.0160 (3.35%)
Inactive · Last trade price on Apr 4, 2025
3.35%
Market Cap4.27M
Revenue (ttm)n/a
Net Income (ttm)-46.50M
Shares Out8.67M
EPS (ttm)-5.62
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume101,498
Average Volume86,248
Open0.4000
Previous Close0.4770
Day's Range0.4000 - 0.4930
52-Week Range0.4000 - 17.2000
Beta-0.21
RSI43.17
Earnings DateMay 2, 2025

About WntResearch AB

WntResearch AB, a biotech company, develops therapies to prevent the metastatic process. The company develops Foxy-5, a peptide, which is in Phase II clinical trials that reduced the risk of metastasis in patients with colon cancer. It is also developing Box-5, a WNT5A antagonist for the treatment of malignant melanoma, and pancreatic and gastric cancer. The company was incorporated in 2007 and is based in Lund, Sweden. [Read more]

Industry Other
Founded 2007
Employees 2
Stock Exchange Nordic Growth Market
Ticker Symbol WNT
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.